178 related articles for article (PubMed ID: 37004354)
21. Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity.
Lu Z; Bauzon F; Fu H; Cui J; Zhao H; Nakayama K; Nakayama KI; Zhu L
Nat Commun; 2014 Mar; 5():3463. PubMed ID: 24632684
[TBL] [Abstract][Full Text] [Related]
22. S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression.
Xu SY; Wang F; Wei G; Wang B; Yang JY; Huang YZ; Zhang L; Zheng F; Guo LY; Wang JN; Tang JM
Cancer Gene Ther; 2013 Dec; 20(12):690-4. PubMed ID: 24336114
[TBL] [Abstract][Full Text] [Related]
23. Targeting the untargetable: RB1-deficient tumours are vulnerable to Skp2 ubiquitin ligase inhibition.
Gupta P; Zhao H; Hoang B; Schwartz EL
Br J Cancer; 2022 Oct; 127(6):969-975. PubMed ID: 35752713
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.
Huang KT; Pavlides SC; Lecanda J; Blank SV; Mittal KR; Gold LI
PLoS One; 2012; 7(9):e46072. PubMed ID: 23029392
[TBL] [Abstract][Full Text] [Related]
25. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
[TBL] [Abstract][Full Text] [Related]
26. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells.
Andreu EJ; Lledó E; Poch E; Ivorra C; Albero MP; Martínez-Climent JA; Montiel-Duarte C; Rifón J; Pérez-Calvo J; Arbona C; Prósper F; Pérez-Roger I
Cancer Res; 2005 Apr; 65(8):3264-72. PubMed ID: 15833859
[TBL] [Abstract][Full Text] [Related]
27. Effects of granulosa cell-specific deletion of Rb in Inha-alpha null female mice.
Andreu-Vieyra C; Chen R; Matzuk MM
Endocrinology; 2007 Aug; 148(8):3837-49. PubMed ID: 17510234
[TBL] [Abstract][Full Text] [Related]
28. A Skp2 autoinduction loop and restriction point control.
Yung Y; Walker JL; Roberts JM; Assoian RK
J Cell Biol; 2007 Aug; 178(5):741-7. PubMed ID: 17724117
[TBL] [Abstract][Full Text] [Related]
29. Global gene deregulations in FASN silenced retinoblastoma cancer cells: molecular and clinico-pathological correlations.
Sangeetha M; Deepa PR; Rishi P; Khetan V; Krishnakumar S
J Cell Biochem; 2015 Nov; 116(11):2676-94. PubMed ID: 25958981
[TBL] [Abstract][Full Text] [Related]
30. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
[TBL] [Abstract][Full Text] [Related]
31. Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression.
Zhang B; Ji LH; Liu W; Zhao G; Wu ZY
World J Gastroenterol; 2013 Aug; 19(30):4917-24. PubMed ID: 23946596
[TBL] [Abstract][Full Text] [Related]
32. p107 inhibits G1 to S phase progression by down-regulating expression of the F-box protein Skp2.
Rodier G; Makris C; Coulombe P; Scime A; Nakayama K; Nakayama KI; Meloche S
J Cell Biol; 2005 Jan; 168(1):55-66. PubMed ID: 15631990
[TBL] [Abstract][Full Text] [Related]
33. Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.
Agarwal A; Bumm TG; Corbin AS; O'Hare T; Loriaux M; VanDyke J; Willis SG; Deininger J; Nakayama KI; Druker BJ; Deininger MW
Blood; 2008 Sep; 112(5):1960-70. PubMed ID: 18559973
[TBL] [Abstract][Full Text] [Related]
34. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma.
Keikhaee MR; Kudo Y; Siriwardena S; Wu L; Ogawa I; Takata T
Virchows Arch; 2007 May; 450(5):567-74. PubMed ID: 17431674
[TBL] [Abstract][Full Text] [Related]
35. Skp2-mediated degradation of p27 regulates progression into mitosis.
Nakayama K; Nagahama H; Minamishima YA; Miyake S; Ishida N; Hatakeyama S; Kitagawa M; Iemura S; Natsume T; Nakayama KI
Dev Cell; 2004 May; 6(5):661-72. PubMed ID: 15130491
[TBL] [Abstract][Full Text] [Related]
36. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
37. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer.
Fagan-Solis KD; Pentecost BT; Gozgit JM; Bentley BA; Marconi SM; Otis CN; Anderton DL; Schneider SS; Arcaro KF
J Cell Physiol; 2014 Sep; 229(9):1160-9. PubMed ID: 24443386
[TBL] [Abstract][Full Text] [Related]
38. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
39. 1,2,3,4,6-penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein.
Huang HC; Lin CL; Lin JK
J Agric Food Chem; 2011 Jun; 59(12):6765-75. PubMed ID: 21598989
[TBL] [Abstract][Full Text] [Related]
40. The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma.
Wang J; Aldahamsheh O; Ferrena A; Borjihan H; Singla A; Yaguare S; Singh S; Viscarret V; Tingling J; Zi X; Lo Y; Gorlick R; Zheng D; Schwartz EL; Zhao H; Yang R; Geller DS; Hoang BH
Ann N Y Acad Sci; 2021 Apr; 1490(1):90-104. PubMed ID: 33594717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
